Brief by Shorts91 Newsdesk / 04:31pm on 29 Apr 2024,Monday Health & Wellness
In a legal battle, AstraZeneca admits its Covid-19 vaccine, including brands Covishield and Vaxzevria, can cause rare side effects like Thrombosis with Thrombocytopenia Syndrome (TTS), involving blood clots and low platelet counts. The pharmaceutical giant faces a class-action lawsuit over alleged serious injuries and deaths. A pivotal moment in the case, AstraZeneca's admission underscores potential risks associated with vaccination. The company's concession follows extensive legal disputes and could result in significant payouts. Despite acknowledging rare side effects, AstraZeneca maintains its vaccine's efficacy while the UK discontinues its use due to safety concerns.
